Cadence Bank Na Eli Lilly & CO Transaction History

Cadence Bank Na

$16.1 Million
Q3 2022

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 20, 2022	SELL	$278.73 - $327.27 $40,973 - $48,108	-147 Reduced 1.38%	10,533 $3.42 Million
Q1 2022 Apr 18, 2022	SELL	$234.69 - $291.66 $2,346 - $2,916	-10 Reduced 0.09%	10,680 $3.06 Million
Q4 2021 Jan 19, 2022	BUY	$224.85 - $279.04 $13,041 - $16,184	58 Added 0.55%	10,690 $2.95 Million
Q3 2021 Oct 22, 2021	SELL	$221.6 - $272.71 $74,236 - $91,357	-335 Reduced 3.05%	10,632 $2.46 Million
Q2 2021 Aug 09, 2021	SELL	$180.55 - $233.54 $41,707 - $53,947	-231 Reduced 2.06%	10,967 $2.52 Million
Q1 2021 May 05, 2021	SELL	$164.32 - $212.72 $21,690 - $28,079	-132 Reduced 1.17%	11,198 $2.09 Million
Q4 2020 Feb 09, 2021	BUY	$130.46 - $172.63 $1,695 - $2,244	13 Added 0.11%	11,330 $1.91 Million
Q3 2020 Oct 23, 2020	BUY	$146.22 - $169.13 $17,985 - $20,802	123 Added 1.1%	11,317 $1.68 Million
Q2 2020 Jul 31, 2020	BUY	$136.42 - $164.18 $29,057 - $34,970	213 Added 1.94%	11,194 $1.84 Million
Q1 2020 May 11, 2020	SELL	$119.05 - $147.35 $760,015 - $940,682	-6,384 Reduced 36.76%	10,981 $1.52 Million
Q4 2019 Feb 13, 2020	SELL	$106.92 - $132.43 $8,232 - $10,197	-77 Reduced 0.44%	17,365 $2.28 Million
Q3 2019 Nov 12, 2019	BUY	$106.79 - $116.16 $64,180 - $69,812	601 Added 3.57%	17,442 $1.95 Million
Q2 2019 Aug 06, 2019	SELL	$110.79 - $129.32 $207,842 - $242,604	-1,876 Reduced 10.02%	16,841 $1.87 Million
Q1 2019 May 09, 2019	SELL	$111.31 - $131.02 $145,148 - $170,850	-1,304 Reduced 6.51%	18,717 $2.43 Million
Q4 2018 Feb 08, 2019	BUY	$105.9 - $118.64 $46,278 - $51,845	437 Added 2.23%	20,021 $2.32 Million
Q3 2018 Nov 06, 2018	SELL	$85.86 - $107.31 $339,490 - $424,303	-3,954 Reduced 16.8%	19,584 $2.1 Million
Q2 2018 Aug 07, 2018	SELL	$75.7 - $86.88 $46,177 - $52,996	-610 Reduced 2.53%	23,538 $2.01 Million
Q1 2018 May 04, 2018	SELL	$74.21 - $87.6 $24,118 - $28,469	-325 Reduced 1.33%	24,148 $1.87 Million
Q4 2017 Feb 02, 2018	BUY	$81.94 - $87.89 $105,620 - $113,290	1,289 Added 5.56%	24,473 $2.07 Million
Q3 2017 Oct 27, 2017	BUY	$77.07 - $85.54 $1.79 Million - $1.98 Million	23,184	23,184 $1.98 Million

Others Institutions Holding LLY

# of Institutions

4,009

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

Lilly Endowment Inc Indianapolis, IN

96.9M
Shares

$78.8 Billion
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

73.8M
Shares

$60 Billion
1.2% of portfolio
Black Rock Inc. New York, NY

65.9M
Shares

$53.6 Billion
1.37% of portfolio
Pnc Financial Services Group, Inc. Pittsburgh, PA

51.4M
Shares

$41.8 Billion
29.2% of portfolio
State Street Corp Boston, MA

33.9M
Shares

$27.5 Billion
1.24% of portfolio

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $773B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cadence Bank Na, based on Form 13F filings with the SEC.

News

Stay updated on Cadence Bank Na with notifications on news.

Account